Echo Pharmaceuticals
About Echo Pharmaceuticals
Echo Pharmaceuticals is a Dutch pharmaceutical company focused on developing cannabinoid-based medicines. The company has worked on oral dosage forms for cannabinoids using proprietary drug delivery technologies, aiming to bring pharmaceutical-grade cannabinoid medicines through the clinical trial process.
Key Facts
- 1Focused on developing pharmaceutical-grade cannabinoid medicines through formal drug approval processes
- 2Developed proprietary oral dosage technology for consistent cannabinoid delivery
- 3Based in Weesp, near Amsterdam, in the Netherlands' pharmaceutical corridor
- 4Aims to bridge the gap between medical cannabis and registered pharmaceutical products
Frequently Asked Questions
How is Echo Pharmaceuticals different from Bedrocan?
Bedrocan provides raw, standardized cannabis plant material, while Echo Pharmaceuticals develops processed pharmaceutical formulations of cannabinoids (pills, oral solutions) that go through formal clinical trials for drug registration, similar to traditional pharmaceutical development.
Are Echo Pharmaceuticals products available?
Echo Pharmaceuticals has been in the development and clinical trial phase. Pharmaceutical drug development is a lengthy process requiring years of trials before products reach the market.
Cannabis Laws
Products
- Cannabinoid pharmaceutical formulations
- Oral dosage forms for THC/CBD
- Drug delivery systems for cannabinoids
- Clinical-stage cannabinoid medicines
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Weesp, Netherlands
- Founded
- 2007
- Publicly Traded
- No